Orpea | Mid-cap | Healthcare

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Income Metrics

Balance Sheet Metrics

Total Assets 13.9B
Total Liabilities 12.0B
Shareholders Equity 1.9B
Debt to Equity 6.36

Cash Flow Metrics

Revenue & Profitability Trend

Orpea Income Statement From 2020 to 2023

Metric2023202220212020
Revenue i5.2B4.7B4.3B3.9B
Cost of Goods Sold i1.1B939.3M731.8M748.8M
Gross Profit i4.1B3.7B3.6B3.2B
Gross Margin % i79.4%79.9%83.0%80.9%
Operating Expenses
Research & Development i----
Selling, General & Administrative i----
Other Operating Expenses i303.1M717.0M250.5M138.3M
Total Operating Expenses i303.1M717.0M250.5M138.3M
Operating Income i-120.7M-664.3M364.6M426.4M
Operating Margin % i-2.3%-14.2%8.5%10.9%
Non-Operating Items
Interest Income i10.0M261.0K433.0K386.0K
Interest Expense i581.7M334.1M210.5M228.2M
Other Non-Operating Income----
Pre-tax Income i1.4B-4.6B105.8M210.3M
Income Tax i44.6M-596.5M37.5M52.6M
Effective Tax Rate % i3.2%0.0%35.5%25.0%
Net Income i1.4B-4.0B66.9M159.3M
Net Margin % i26.2%-86.0%1.6%4.1%
Key Metrics
EBITDA i3.6B141.1M1.0B930.4M
EPS (Basic) i-€-61,913.99€64.50€158.38
EPS (Diluted) i-€-61,913.99€60.67€155.83
Basic Shares Outstanding i-6504210111821011137
Diluted Shares Outstanding i-6504210111821011137

Income Statement Trend

Orpea Balance Sheet From 2019 to 2023

Metric20232022202120202019
Assets
Current Assets
Cash & Equivalents i645.0M856.4M952.4M888.8M-
Short-term Investments i-----
Accounts Receivable i518.1M455.4M431.6M233.2M-
Inventory i15.6M16.1M15.7M19.8M-
Other Current Assets-----
Total Current Assets i2.4B2.3B2.8B2.4B-
Non-Current Assets
Property, Plant & Equipment i11.3B11.5B10.5B10.9B-
Goodwill i4.3B4.3B6.4B5.9B-
Intangible Assets i1.5B1.6B3.1B2.9B-
Long-term Investments24.2M84.4M0--
Other Non-Current Assets--3.0K1.0K1.0K-
Total Non-Current Assets i11.5B12.2B14.3B14.6B-
Total Assets i13.9B14.5B17.1B17.0B-
Liabilities
Current Liabilities
Accounts Payable i502.3M327.0M334.8M310.4M-
Short-term Debt i1.3B8.6B2.2B1.3B-
Current Portion of Long-term Debt-----
Other Current Liabilities-280.6M412.8M422.5M249.9M
Total Current Liabilities i3.1B10.0B3.5B2.6B-
Non-Current Liabilities
Long-term Debt i7.9B4.8B10.0B9.2B-
Deferred Tax Liabilities i662.5M814.0M997.0M1.4B-
Other Non-Current Liabilities-1.0K-2.0K2.0K-
Total Non-Current Liabilities i8.9B6.0B11.2B10.8B-
Total Liabilities i12.0B16.0B14.7B13.5B-
Equity
Common Stock i1.3B80.9M80.8M80.8M-
Retained Earnings i1.4B-4.0B65.2M160.0M-
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i1.9B-1.5B2.3B3.5B-
Key Metrics
Total Debt i9.2B13.4B12.1B10.5B0
Working Capital i-751.5M-7.7B-738.1M-223.2M0

Balance Sheet Composition

Orpea Cash Flow Statement From 2020 to 2023

Metric2023202220212020
Operating Activities
Net Income i1.4B-4.0B66.9M160.0M
Depreciation & Amortization i----
Stock-Based Compensation i----
Working Capital Changes i-148.2M-262.1M-218.1M-106.6M
Operating Cash Flow i-467.9M-102.5M677.0M693.9M
Investing Activities
Capital Expenditures i-141.0M-136.3M--
Acquisitions i-8.2M-28.7M-421.9M-494.4M
Investment Purchases i----
Investment Sales i----
Investing Cash Flow i-149.2M-165.0M-421.9M-988.9M
Financing Activities
Share Repurchases i----
Dividends Paid i---58.2M-
Debt Issuance i500.0M3.4B2.3B1.7B
Debt Repayment i-972.0M-2.5B-991.9M-933.5M
Financing Cash Flow i688.1M898.4M1.3B811.0M
Free Cash Flow i225.1M273.4M753.8M777.7M
Net Change in Cash i71.0M630.9M1.5B516.0M

Cash Flow Trend

Orpea Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 0.10
Forward P/E 41.04
Price to Book 0.85
Price to Sales 0.38
PEG Ratio 41.04

Profitability Ratios

Profit Margin 26.07%
Operating Margin -0.11%
Return on Equity 704.66%
Return on Assets -0.07%

Financial Health

Current Ratio 0.76
Debt to Equity 485.11
Beta 0.72

Per Share Data

EPS (TTM) €129.13
Book Value per Share €14.53
Revenue per Share €501.00

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
orp2.0B0.100.85704.66%26.07%485.11
Emeis S.A 2.1B0.021.20-23.02%-7.31%514.45
Clariene SE 1.6B9.760.43-1.54%-1.16%209.58
Lna Santé S.A 286.3M13.100.917.25%2.71%270.87
Ramsay Générale de 1.1B34.130.99-5.16%-1.55%337.92
EssilorLuxottica 118.0B48.883.076.44%8.74%36.58

Financial data is updated regularly. All figures are in the company's reporting currency.